<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7608025</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6790</journal-id>
<journal-id journal-id-type="nlm-ta">Psychopharmacology (Berl)</journal-id>
<journal-id journal-id-type="iso-abbrev">Psychopharmacology (Berl.)</journal-id>
<journal-title-group>
<journal-title>Psychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0033-3158</issn>
<issn pub-type="epub">1432-2072</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29663017</article-id>
<article-id pub-id-type="pmc">5949271</article-id>
<article-id pub-id-type="doi">10.1007/s00213-018-4895-7</article-id>
<article-id pub-id-type="manuscript">NIHMS960357</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cyclic nucleotide phosphodiesterases: Potential therapeutic targets for alcohol use disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Rui-Ting</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Fang-Fang</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Han-Ting</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pharmacy, Peking University Peopleâ€™s Hospital, Beijing 100044, China</aff>
<aff id="A2">
<label>2</label>Institute of Pharmacology, Qilu Medical University, Taian, Shandong 271016, China</aff>
<aff id="A3">
<label>3</label>Departments of Behavioral Medicine &amp; Psychiatry and Physiology, Pharmacology &amp; Neuroscience, Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence: <email>hzhang@hsc.wvu.edu</email>; Tel: +1-304-293-1488</corresp>
<fn fn-type="equal" id="FN2">
<label>#</label>
<p>Equally contributed.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>235</volume>
<issue>6</issue>
<fpage>1793</fpage>
<lpage>1805</lpage>
<!--elocation-id from pubmed: 10.1007/s00213-018-4895-7-->
<abstract>
<p id="P1">Alcohol use disorder (AUD), which combines the criteria of both alcohol abuse and dependence, contributes as an important causal factor to multiple health and social problems. Given the limitation of current treatments, novel medications for AUD are needed to better control alcohol consumption and maintain abstinence. It has been well established that the intracellular signal transduction mediated by the second messengers cyclic AMP (cAMP) and cyclic GMP (cGMP) crucially underlies the genetic predisposition, rewarding properties, relapsing features, and systemic toxicity of compulsive alcohol consumption. On this basis, the upstream modulators phosphodiesterases (PDEs), which critically control intracellular levels of cyclic nucleotides by catalyzing their degradation, are proposed to play a role in modulating alcohol abuse and dependent process. Here we highlight existing evidence that correlates cAMP and cGMP signal cascades with the regulation of alcohol drinking behavior and discuss the possibility that PDEs may become a novel class of therapeutic targets for AUD.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>